CBD spray calms Alzheimer's anxiety? early trial hints at relief
NCT ID NCT04075435
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small, early-stage study tested a high-CBD, low-THC liquid spray for 8 weeks in 12 older adults with mild cognitive impairment or mild-to-moderate Alzheimer's who also had significant anxiety or agitation. The goal was to see if the treatment could reduce these behavioral symptoms safely. The study is now complete and not recruiting new participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION,PSYCHOMOTOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McLean Hospital
Belmont, Massachusetts, 02478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?